YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

GlaxoSmithKline chairman to step down ahead of split

Posted online

GlaxoSmithKline Plc Chairman Philip Hampton announced he'll step down after more than three years in the role.

The decision comes ahead of the United Kingdom's largest drugmaker splitting into two businesses: one for prescription drugs and vaccines and one for over-the-counter products.

"I believe this is the right moment to step down and allow a new chair to oversee this process through to its conclusion over the next few years," Hampton said in a statement.

Read more from Reuters.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences